VIZAMYL Trademark

Trademark Overview

On Tuesday, May 24, 2011, a trademark application was filed for VIZAMYL with the United States Patent and Trademark Office. The USPTO has given the VIZAMYL trademark a serial number of 85328526. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, March 9, 2021. This trademark is owned by GE Healthcare Limited. The VIZAMYL trademark is filed in the Pharmaceutical Products category with the following description:

Contrast media for in-vivo imaging; Diagnostic preparations for medical purposes; Radiopharmaceutical agents for use in amyloid pathology detection
vizamyl

General Information

Serial Number85328526
Word MarkVIZAMYL
Filing DateTuesday, May 24, 2011
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, March 9, 2021
Registration Number4659887
Registration DateTuesday, December 23, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2011

Trademark Statements

Goods and ServicesContrast media for in-vivo imaging; Diagnostic preparations for medical purposes; Radiopharmaceutical agents for use in amyloid pathology detection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 27, 2011
Primary Code005
First Use Anywhere DateThursday, September 11, 2014
First Use In Commerce DateThursday, September 11, 2014

Trademark Owner History

Party NameGE Healthcare Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressChalfont St Giles HP84SP
GB
Party NameGE Healthcare Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBuckinghamshire HP79NA
GB
Party NameGE Healthcare Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBuckinghamshire HP79NA
GB

Trademark Events

Event DateEvent Description
Thursday, March 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 23, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, October 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 27, 2023TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Tuesday, June 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, January 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, January 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, January 7, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, January 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, January 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 9, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, March 9, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 4, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 1, 2020TEAS SECTION 8 & 15 RECEIVED
Monday, December 23, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 23, 2014REGISTERED-PRINCIPAL REGISTER
Friday, November 21, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, November 20, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 30, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, October 13, 2014USE AMENDMENT FILED
Monday, October 13, 2014TEAS STATEMENT OF USE RECEIVED
Friday, June 6, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 5, 2014SOU EXTENSION 5 GRANTED
Monday, June 2, 2014SOU EXTENSION 5 FILED
Monday, June 2, 2014SOU TEAS EXTENSION RECEIVED
Friday, May 30, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 5, 2013SOU EXTENSION 4 GRANTED
Tuesday, December 3, 2013SOU EXTENSION 4 FILED
Tuesday, December 3, 2013SOU TEAS EXTENSION RECEIVED
Tuesday, June 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2013SOU EXTENSION 3 GRANTED
Monday, May 20, 2013SOU EXTENSION 3 FILED
Monday, June 17, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 20, 2013SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, November 24, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 23, 2012SOU EXTENSION 2 GRANTED
Monday, November 19, 2012SOU EXTENSION 2 FILED
Monday, November 19, 2012SOU TEAS EXTENSION RECEIVED
Thursday, November 15, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 3, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 30, 2012SOU EXTENSION 1 GRANTED
Thursday, June 7, 2012SOU EXTENSION 1 FILED
Friday, June 29, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 7, 2012SOU TEAS EXTENSION RECEIVED
Wednesday, June 6, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 13, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 18, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2011PUBLISHED FOR OPPOSITION
Monday, September 12, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 9, 2011ASSIGNED TO EXAMINER
Friday, May 27, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 27, 2011NEW APPLICATION ENTERED

Related Keywords

vizamyl agents radiopharmaceutical amyloid pathology detection purposes medical vivo media imaging